Daejeon, South Korea

Ye Jin Jang

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Na Vaccine Institute, Seoul National University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ye Jin Jang. Retrieved from https://idiyas.com/inventor/ye-jin-jang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ye Jin Jang - Innovator in Influenza Vaccine Development

Introduction

Ye Jin Jang is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of vaccine development, particularly in the area of influenza. Her innovative work has the potential to enhance public health and improve vaccine efficacy.

Latest Patents

Ye Jin Jang holds a patent for an "Influenza Vaccine Composition Based on Novel Nucleic Acid." This patent represents a breakthrough in the development of more effective influenza vaccines, showcasing her commitment to advancing medical science.

Career Highlights

Jang is affiliated with the Na Vaccine Institute, where she collaborates with other researchers to push the boundaries of vaccine technology. Her work is characterized by a focus on innovative solutions to combat infectious diseases.

Collaborations

She has worked alongside notable colleagues, including Eui Ho Kim and Myung Soo Kang. These collaborations have fostered a dynamic research environment that encourages the exchange of ideas and expertise.

Conclusion

Ye Jin Jang's contributions to vaccine development, particularly her patented work on influenza vaccines, highlight her role as a key innovator in the field. Her dedication to research and collaboration continues to pave the way for advancements in public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…